Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Vitamin A Use in Retinitis Pigmentosa (RP) Patients

Josifova T.1, Ivanovska M.1, Blazevska K.1, Zlateva G.1, Peter S.2
1University Ophthalmology Clinic, Skopje/MAK; 2Augenarztpraxis, Luzern/CH

Purpose: The aim of this study is to show whether the use of vitamin A palmitate in RP patients has advantages over the use of vitamin A in carotinoides.
Method: 23 patients who had used vitamin A palmitate for three years, as well as 31 patients who had used the antioxidant therapy with tabl. of Spirulina pacifica were included in the study. The dosage of vitamin A palmitate was 15.000 IU/day for adults, or 5.000 IU/day, 10.000 IU/day and 15.000 IU/day for children, depending on the age of the child. Tablets of Spirulina pacifica that contain alfa and beta carotinoides and zeaxanthin were taken in daily dosage of 6-10 tablets for adults and 3-6 for chlidren. Supplementation of vit E for adults was in 400 IU/day. Investigation tests of the Visual Acuity, Visual Feeld, Fluorescein Angiography and Electroretinography were performed together with fasting serum A and liver function profile.
Results: After three years of therapy in the A palmitate group, 15/23 (65.2%) had no progression of the disease. Worsening of the condition was detected in 3/23 (13.0%), and intermediate therapy effect increase in 5/23 (21.7%). 18/31 (58.0%) patients treated with carotinoides had the same results as before the therapy. Worsening of the condition was detected in 6/31(19.3%), and intermediate in


Zurück | Back